| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | AB | AC | AD | AE | AF | AG | AH | AI | AJ | AK | AL | AM | AN | AO | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Patient ID | Sample ID | Format (Plasma, Serum, etc.) | Type of vacutainer | Sample volume, ml | Gender | Age | Race | Ethnicity | Organ | Clinical Diagnosis | Pathological Diagnosis | Cancer / Non-cancer | T | N | M | Grade | Stage | Tumor size, cm | HIV | HEP B | HEP C | Donor's Height, cm | Donor's Weight, kg | Current Medications | Smoking (yes, no) | Smoking: Type | Smoking: Pack / Day | Smoking: Duration (years) | Alcohol | Drug Use | Hormonal Therapy | Prev. Chemotherapy | Prev. Radiation | Current Procedure / Surgery | Date of Procurement | Country of Collection | Clinical Site | Collection Protocol | Ethics and Informed Consent | |
2 | 02-29840 | 02-29840-PL1 | Plasma | K2EDTA | 1.8 | Female | 53 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial intraepithelial neoplasia | Pre-cancer | Neg | Neg | Neg | No | No | No | No | No | No | No | Panhysterectomy | 15-Dec-2020 | Ukraine | CHD | Prospective | Active | ||||||||||||
3 | 02-29840 | 02-29840-PL2 | Plasma | K2EDTA | 1.8 | Female | 53 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial intraepithelial neoplasia | Pre-cancer | Neg | Neg | Neg | No | No | No | No | No | No | No | Panhysterectomy | 15-Dec-2020 | Ukraine | CHD | Prospective | Active | ||||||||||||
4 | 02-29840 | 02-29840-PL3 | Plasma | K2EDTA | 1.8 | Female | 53 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial intraepithelial neoplasia | Pre-cancer | Neg | Neg | Neg | No | No | No | No | No | No | No | Panhysterectomy | 15-Dec-2020 | Ukraine | CHD | Prospective | Active | ||||||||||||
5 | 02-29840 | 02-29840-PL4 | Plasma | K2EDTA | 1.8 | Female | 53 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial intraepithelial neoplasia | Pre-cancer | Neg | Neg | Neg | No | No | No | No | No | No | No | Panhysterectomy | 15-Dec-2020 | Ukraine | CHD | Prospective | Active | ||||||||||||
6 | 02-29840 | 02-29840-PL5 | Plasma | K2EDTA | 1.8 | Female | 53 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial intraepithelial neoplasia | Pre-cancer | Neg | Neg | Neg | No | No | No | No | No | No | No | Panhysterectomy | 15-Dec-2020 | Ukraine | CHD | Prospective | Active | ||||||||||||
7 | 02-29840 | 02-29840-PL6 | Plasma | K2EDTA | 1.8 | Female | 53 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial intraepithelial neoplasia | Pre-cancer | Neg | Neg | Neg | No | No | No | No | No | No | No | Panhysterectomy | 15-Dec-2020 | Ukraine | CHD | Prospective | Active | ||||||||||||
8 | 02-29840 | 02-29840-PL7 | Plasma | K2EDTA | 1.8 | Female | 53 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial intraepithelial neoplasia | Pre-cancer | Neg | Neg | Neg | No | No | No | No | No | No | No | Panhysterectomy | 15-Dec-2020 | Ukraine | CHD | Prospective | Active | ||||||||||||
9 | 02-29840 | 02-29840-PL8 | Plasma | K2EDTA | 1.8 | Female | 53 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial intraepithelial neoplasia | Pre-cancer | Neg | Neg | Neg | No | No | No | No | No | No | No | Panhysterectomy | 15-Dec-2020 | Ukraine | CHD | Prospective | Active | ||||||||||||
10 | 02-29840 | 02-29840-PL9 | Plasma | K2EDTA | 1.6 | Female | 53 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial intraepithelial neoplasia | Pre-cancer | Neg | Neg | Neg | No | No | No | No | No | No | No | Panhysterectomy | 15-Dec-2020 | Ukraine | CHD | Prospective | Active | ||||||||||||
11 | 02-29840 | 02-29840-PL10 | Plasma | K2EDTA | 1.8 | Female | 53 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial intraepithelial neoplasia | Pre-cancer | Neg | Neg | Neg | No | No | No | No | No | No | No | Panhysterectomy | 15-Dec-2020 | Ukraine | CHD | Prospective | Active | ||||||||||||
12 | 23648 | 23648-PL5 | Plasma | K2EDTA | 2 | Female | 81 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1a | Nx | Mx | G1 | IA | Neg | Neg | Neg | 155 | 68 | No | No | No | No | No | No | No | Panhysterectomy type I | 11-Feb-2020 | Ukraine | POLOD | Prospective | Active | |||||
13 | 23648 | 23648-PL6 | Plasma | K2EDTA | 2 | Female | 81 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1a | Nx | Mx | G1 | IA | Neg | Neg | Neg | 155 | 68 | No | No | No | No | No | No | No | Panhysterectomy type I | 11-Feb-2020 | Ukraine | POLOD | Prospective | Active | |||||
14 | 23648 | 23648-PL7 | Plasma | K2EDTA | 2 | Female | 81 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1a | Nx | Mx | G1 | IA | Neg | Neg | Neg | 155 | 68 | No | No | No | No | No | No | No | Panhysterectomy type I | 11-Feb-2020 | Ukraine | POLOD | Prospective | Active | |||||
15 | 23648 | 23648-PL8 | Plasma | K2EDTA | 2 | Female | 81 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1a | Nx | Mx | G1 | IA | Neg | Neg | Neg | 155 | 68 | No | No | No | No | No | No | No | Panhysterectomy type I | 11-Feb-2020 | Ukraine | POLOD | Prospective | Active | |||||
16 | 23648 | 23648-PL9 | Plasma | K2EDTA | 2 | Female | 81 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1a | Nx | Mx | G1 | IA | Neg | Neg | Neg | 155 | 68 | No | No | No | No | No | No | No | Panhysterectomy type I | 11-Feb-2020 | Ukraine | POLOD | Prospective | Active | |||||
17 | 23648 | 23648-PL10 | Plasma | K2EDTA | 2 | Female | 81 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1a | Nx | Mx | G1 | IA | Neg | Neg | Neg | 155 | 68 | No | No | No | No | No | No | No | Panhysterectomy type I | 11-Feb-2020 | Ukraine | POLOD | Prospective | Active | |||||
18 | 25177 | 25177-PL1 | Plasma | K2EDTA | 5.5 | Female | 48 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | T3a | N0 | M0 | G2 | IIIA | Whole uterine cavity | Neg | Neg | Neg | 162 | 75 | No | No | No | No | No | No | No | Panhysterectomy | 26-Feb-2020 | Ukraine | SVT4 | Prospective | Active | ||||
19 | 25177 | 25177-PL2 | Plasma | K2EDTA | 5.5 | Female | 48 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | T3a | N0 | M0 | G2 | IIIA | Whole uterine cavity | Neg | Neg | Neg | 162 | 75 | No | No | No | No | No | No | No | Panhysterectomy | 26-Feb-2020 | Ukraine | SVT4 | Prospective | Active | ||||
20 | 24337 | 24337-PL1 | Plasma | K2EDTA | 5.5 | Female | 37 | Caucasian | Slavic | Uterus | Uterine cancer | Mucinous adenocarcinoma | Cancer | T1b | N1 | M0 | G2 | IB | 4 | Neg | Neg | Neg | 160 | 92 | No | No | No | No | No | No | No | Panhysterectomy | 14-Feb-2020 | Ukraine | SVT4 | Prospective | Active | ||||
21 | 24337 | 24337-PL2 | Plasma | K2EDTA | 5.5 | Female | 37 | Caucasian | Slavic | Uterus | Uterine cancer | Mucinous adenocarcinoma | Cancer | T1b | N1 | M0 | G2 | IB | 4 | Neg | Neg | Neg | 160 | 92 | No | No | No | No | No | No | No | Panhysterectomy | 14-Feb-2020 | Ukraine | SVT4 | Prospective | Active | ||||
22 | 723313 | 723313-A1 | Plasma | 1.8 | Female | 42 | Caucasian | Slavic | Uterus | Uterine cancer | Atypical endometrial hyperplasia | Non-cancer | Neg | Neg | Neg | 172 | 72 | No | No | No | No | No | No | No | Panhysterectomy type III | 17-Oct-2018 | Ukraine | KRE | Prospective | Active | |||||||||||
23 | 723313 | 723313-A2 | Plasma | 1.8 | Female | 42 | Caucasian | Slavic | Uterus | Uterine cancer | Atypical endometrial hyperplasia | Non-cancer | Neg | Neg | Neg | 172 | 72 | No | No | No | No | No | No | No | Panhysterectomy type III | 17-Oct-2018 | Ukraine | KRE | Prospective | Active | |||||||||||
24 | 723313 | 723313-A3 | Plasma | 1.8 | Female | 42 | Caucasian | Slavic | Uterus | Uterine cancer | Atypical endometrial hyperplasia | Non-cancer | Neg | Neg | Neg | 172 | 72 | No | No | No | No | No | No | No | Panhysterectomy type III | 17-Oct-2018 | Ukraine | KRE | Prospective | Active | |||||||||||
25 | 723313 | 723313-A4 | Plasma | 1.8 | Female | 42 | Caucasian | Slavic | Uterus | Uterine cancer | Atypical endometrial hyperplasia | Non-cancer | Neg | Neg | Neg | 172 | 72 | No | No | No | No | No | No | No | Panhysterectomy type III | 17-Oct-2018 | Ukraine | KRE | Prospective | Active | |||||||||||
26 | 723313 | 723313-A5 | Plasma | 1.8 | Female | 42 | Caucasian | Slavic | Uterus | Uterine cancer | Atypical endometrial hyperplasia | Non-cancer | Neg | Neg | Neg | 172 | 72 | No | No | No | No | No | No | No | Panhysterectomy type III | 17-Oct-2018 | Ukraine | KRE | Prospective | Active | |||||||||||
27 | 723313 | 723313-A6 | Plasma | 1.8 | Female | 42 | Caucasian | Slavic | Uterus | Uterine cancer | Atypical endometrial hyperplasia | Non-cancer | Neg | Neg | Neg | 172 | 72 | No | No | No | No | No | No | No | Panhysterectomy type III | 17-Oct-2018 | Ukraine | KRE | Prospective | Active | |||||||||||
28 | 723313 | 723313-A7 | Plasma | 1.8 | Female | 42 | Caucasian | Slavic | Uterus | Uterine cancer | Atypical endometrial hyperplasia | Non-cancer | Neg | Neg | Neg | 172 | 72 | No | No | No | No | No | No | No | Panhysterectomy type III | 17-Oct-2018 | Ukraine | KRE | Prospective | Active | |||||||||||
29 | 723313 | 723313-A8 | Plasma | 1.8 | Female | 42 | Caucasian | Slavic | Uterus | Uterine cancer | Atypical endometrial hyperplasia | Non-cancer | Neg | Neg | Neg | 172 | 72 | No | No | No | No | No | No | No | Panhysterectomy type III | 17-Oct-2018 | Ukraine | KRE | Prospective | Active | |||||||||||
30 | 723313 | 723313-A9 | Plasma | 1.8 | Female | 42 | Caucasian | Slavic | Uterus | Uterine cancer | Atypical endometrial hyperplasia | Non-cancer | Neg | Neg | Neg | 172 | 72 | No | No | No | No | No | No | No | Panhysterectomy type III | 17-Oct-2018 | Ukraine | KRE | Prospective | Active | |||||||||||
31 | 723313 | 723313-A10 | Plasma | 1.8 | Female | 42 | Caucasian | Slavic | Uterus | Uterine cancer | Atypical endometrial hyperplasia | Non-cancer | Neg | Neg | Neg | 172 | 72 | No | No | No | No | No | No | No | Panhysterectomy type III | 17-Oct-2018 | Ukraine | KRE | Prospective | Active | |||||||||||
32 | 24765 | 24765-PL1 | Plasma | K2EDTA | 2 | Female | 68 | Caucasian | Slavic | Uterus | Uterine cancer | Adenocarcinoma, need IHC | Cancer | Neg | Neg | Neg | Polypectomy | 6-Feb-2020 | Ukraine | KHO | Prospective | Active | |||||||||||||||||||
33 | 24765 | 24765-PL2 | Plasma | K2EDTA | 2 | Female | 68 | Caucasian | Slavic | Uterus | Uterine cancer | Adenocarcinoma, need IHC | Cancer | Neg | Neg | Neg | Polypectomy | 6-Feb-2020 | Ukraine | KHO | Prospective | Active | |||||||||||||||||||
34 | 24765 | 24765-PL3 | Plasma | K2EDTA | 2 | Female | 68 | Caucasian | Slavic | Uterus | Uterine cancer | Adenocarcinoma, need IHC | Cancer | Neg | Neg | Neg | Polypectomy | 6-Feb-2020 | Ukraine | KHO | Prospective | Active | |||||||||||||||||||
35 | 24765 | 24765-PL4 | Plasma | K2EDTA | 2 | Female | 68 | Caucasian | Slavic | Uterus | Uterine cancer | Adenocarcinoma, need IHC | Cancer | Neg | Neg | Neg | Polypectomy | 6-Feb-2020 | Ukraine | KHO | Prospective | Active | |||||||||||||||||||
36 | 24765 | 24765-PL5 | Plasma | K2EDTA | 2 | Female | 68 | Caucasian | Slavic | Uterus | Uterine cancer | Adenocarcinoma, need IHC | Cancer | Neg | Neg | Neg | Polypectomy | 6-Feb-2020 | Ukraine | KHO | Prospective | Active | |||||||||||||||||||
37 | 24765 | 24765-PL6 | Plasma | K2EDTA | 2 | Female | 68 | Caucasian | Slavic | Uterus | Uterine cancer | Adenocarcinoma, need IHC | Cancer | Neg | Neg | Neg | Polypectomy | 6-Feb-2020 | Ukraine | KHO | Prospective | Active | |||||||||||||||||||
38 | 24765 | 24765-PL7 | Plasma | K2EDTA | 2 | Female | 68 | Caucasian | Slavic | Uterus | Uterine cancer | Adenocarcinoma, need IHC | Cancer | Neg | Neg | Neg | Polypectomy | 6-Feb-2020 | Ukraine | KHO | Prospective | Active | |||||||||||||||||||
39 | 24765 | 24765-PL8 | Plasma | K2EDTA | 2 | Female | 68 | Caucasian | Slavic | Uterus | Uterine cancer | Adenocarcinoma, need IHC | Cancer | Neg | Neg | Neg | Polypectomy | 6-Feb-2020 | Ukraine | KHO | Prospective | Active | |||||||||||||||||||
40 | 24765 | 24765-PL9 | Plasma | K2EDTA | 2 | Female | 68 | Caucasian | Slavic | Uterus | Uterine cancer | Adenocarcinoma, need IHC | Cancer | Neg | Neg | Neg | Polypectomy | 6-Feb-2020 | Ukraine | KHO | Prospective | Active | |||||||||||||||||||
41 | 24765 | 24765-PL10 | Plasma | K2EDTA | 2 | Female | 68 | Caucasian | Slavic | Uterus | Uterine cancer | Adenocarcinoma, need IHC | Cancer | Neg | Neg | Neg | Polypectomy | 6-Feb-2020 | Ukraine | KHO | Prospective | Active | |||||||||||||||||||
42 | 02-31603 | 02-31603-PL1 | Plasma | K2EDTA | 1.5 | Female | 62 | Caucasian | Slavic | Uterus | Uterine cancer | Serous carcinoma, need IHC | Cancer | T1b | N0 | M0 | G2 | IB | Neg | Neg | Neg | 158 | 104 | Metformin 850 mg | No | No | No | No | No | No | Panhysterectomy | 24-Nov-2020 | Ukraine | TOD | Prospective | Active | |||||
43 | 02-31603 | 02-31603-PL2 | Plasma | K2EDTA | 1.5 | Female | 62 | Caucasian | Slavic | Uterus | Uterine cancer | Serous carcinoma, need IHC | Cancer | T1b | N0 | M0 | G2 | IB | Neg | Neg | Neg | 158 | 104 | Metformin 850 mg | No | No | No | No | No | No | Panhysterectomy | 24-Nov-2020 | Ukraine | TOD | Prospective | Active | |||||
44 | 02-31603 | 02-31603-PL3 | Plasma | K2EDTA | 1.5 | Female | 62 | Caucasian | Slavic | Uterus | Uterine cancer | Serous carcinoma, need IHC | Cancer | T1b | N0 | M0 | G2 | IB | Neg | Neg | Neg | 158 | 104 | Metformin 850 mg | No | No | No | No | No | No | Panhysterectomy | 24-Nov-2020 | Ukraine | TOD | Prospective | Active | |||||
45 | 02-31603 | 02-31603-PL4 | Plasma | K2EDTA | 1.5 | Female | 62 | Caucasian | Slavic | Uterus | Uterine cancer | Serous carcinoma, need IHC | Cancer | T1b | N0 | M0 | G2 | IB | Neg | Neg | Neg | 158 | 104 | Metformin 850 mg | No | No | No | No | No | No | Panhysterectomy | 24-Nov-2020 | Ukraine | TOD | Prospective | Active | |||||
46 | 02-31603 | 02-31603-PL5 | Plasma | K2EDTA | 1.5 | Female | 62 | Caucasian | Slavic | Uterus | Uterine cancer | Serous carcinoma, need IHC | Cancer | T1b | N0 | M0 | G2 | IB | Neg | Neg | Neg | 158 | 104 | Metformin 850 mg | No | No | No | No | No | No | Panhysterectomy | 24-Nov-2020 | Ukraine | TOD | Prospective | Active | |||||
47 | 02-31603 | 02-31603-PL6 | Plasma | K2EDTA | 1.5 | Female | 62 | Caucasian | Slavic | Uterus | Uterine cancer | Serous carcinoma, need IHC | Cancer | T1b | N0 | M0 | G2 | IB | Neg | Neg | Neg | 158 | 104 | Metformin 850 mg | No | No | No | No | No | No | Panhysterectomy | 24-Nov-2020 | Ukraine | TOD | Prospective | Active | |||||
48 | 02-31603 | 02-31603-PL7 | Plasma | K2EDTA | 1.5 | Female | 62 | Caucasian | Slavic | Uterus | Uterine cancer | Serous carcinoma, need IHC | Cancer | T1b | N0 | M0 | G2 | IB | Neg | Neg | Neg | 158 | 104 | Metformin 850 mg | No | No | No | No | No | No | Panhysterectomy | 24-Nov-2020 | Ukraine | TOD | Prospective | Active | |||||
49 | 02-31603 | 02-31603-PL8 | Plasma | K2EDTA | 1.5 | Female | 62 | Caucasian | Slavic | Uterus | Uterine cancer | Serous carcinoma, need IHC | Cancer | T1b | N0 | M0 | G2 | IB | Neg | Neg | Neg | 158 | 104 | Metformin 850 mg | No | No | No | No | No | No | Panhysterectomy | 24-Nov-2020 | Ukraine | TOD | Prospective | Active | |||||
50 | 02-31603 | 02-31603-PL9 | Plasma | K2EDTA | 1.5 | Female | 62 | Caucasian | Slavic | Uterus | Uterine cancer | Serous carcinoma, need IHC | Cancer | T1b | N0 | M0 | G2 | IB | Neg | Neg | Neg | 158 | 104 | Metformin 850 mg | No | No | No | No | No | No | Panhysterectomy | 24-Nov-2020 | Ukraine | TOD | Prospective | Active | |||||
51 | 02-31603 | 02-31603-PL10 | Plasma | K2EDTA | 1.5 | Female | 62 | Caucasian | Slavic | Uterus | Uterine cancer | Serous carcinoma, need IHC | Cancer | T1b | N0 | M0 | G2 | IB | Neg | Neg | Neg | 158 | 104 | Metformin 850 mg | No | No | No | No | No | No | Panhysterectomy | 24-Nov-2020 | Ukraine | TOD | Prospective | Active | |||||
52 | 20854 | 20854-SST1 | Serum | SST | 2 | Female | 55 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | T1b | Nx | Mx | IB | 3х2х1,5cm | Neg | Neg | Neg | 168 | 110 | No | No | No | No | No | No | No | Panhysterectomy | 27-Mar-2019 | Ukraine | POL | Prospective | Active | |||||
53 | 20854 | 20854-SST2 | Serum | SST | 2 | Female | 55 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | T1b | Nx | Mx | IB | 3х2х1,5cm | Neg | Neg | Neg | 168 | 110 | No | No | No | No | No | No | No | Panhysterectomy | 27-Mar-2019 | Ukraine | POL | Prospective | Active | |||||
54 | 20854 | 20854-SST3 | Serum | SST | 2 | Female | 55 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | T1b | Nx | Mx | IB | 3х2х1,5cm | Neg | Neg | Neg | 168 | 110 | No | No | No | No | No | No | No | Panhysterectomy | 27-Mar-2019 | Ukraine | POL | Prospective | Active | |||||
55 | 20854 | 20854-SST4 | Serum | SST | 2 | Female | 55 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | T1b | Nx | Mx | IB | 3х2х1,5cm | Neg | Neg | Neg | 168 | 110 | No | No | No | No | No | No | No | Panhysterectomy | 27-Mar-2019 | Ukraine | POL | Prospective | Active | |||||
56 | 20854 | 20854-SST5 | Serum | SST | 2 | Female | 55 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | T1b | Nx | Mx | IB | 3х2х1,5cm | Neg | Neg | Neg | 168 | 110 | No | No | No | No | No | No | No | Panhysterectomy | 27-Mar-2019 | Ukraine | POL | Prospective | Active | |||||
57 | 20854 | 20854-SST6 | Serum | SST | 2 | Female | 55 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | T1b | Nx | Mx | IB | 3х2х1,5cm | Neg | Neg | Neg | 168 | 110 | No | No | No | No | No | No | No | Panhysterectomy | 27-Mar-2019 | Ukraine | POL | Prospective | Active | |||||
58 | 02-31632 | 025-31632-PL1 | Plasma | K2EDTA | 2 | Female | 38 | Caucasian | Slavic | Uterus | Uterine cancer | Squamous intraepithelial lesion | Non-cancer | 2,5*0,8*0,8 | Neg | Neg | Neg | 163 | 47 | No | No | No | No | No | No | No | Resection | 14-Dec-2020 | Ukraine | INO | Prospective | Active | |||||||||
59 | 02-31632 | 025-31632-PL2 | Plasma | K2EDTA | 2 | Female | 38 | Caucasian | Slavic | Uterus | Uterine cancer | Squamous intraepithelial lesion | Non-cancer | 2,5*0,8*0,8 | Neg | Neg | Neg | 163 | 47 | No | No | No | No | No | No | No | Hysterectomy | 14-Dec-2020 | Ukraine | INO | Prospective | Active | |||||||||
60 | 02-31632 | 025-31632-PL3 | Plasma | K2EDTA | 2 | Female | 38 | Caucasian | Slavic | Uterus | Uterine cancer | Squamous intraepithelial lesion | Non-cancer | 2,5*0,8*0,8 | Neg | Neg | Neg | 163 | 47 | No | No | No | No | No | No | No | Hysterectomy | 14-Dec-2020 | Ukraine | INO | Prospective | Active | |||||||||
61 | 02-31632 | 025-31632-PL4 | Plasma | K2EDTA | 2 | Female | 38 | Caucasian | Slavic | Uterus | Uterine cancer | Squamous intraepithelial lesion | Non-cancer | 2,5*0,8*0,8 | Neg | Neg | Neg | 163 | 47 | No | No | No | No | No | No | No | Hysterectomy | 14-Dec-2020 | Ukraine | INO | Prospective | Active | |||||||||
62 | 02-31632 | 025-31632-PL5 | Plasma | K2EDTA | 2 | Female | 38 | Caucasian | Slavic | Uterus | Uterine cancer | Squamous intraepithelial lesion | Non-cancer | 2,5*0,8*0,8 | Neg | Neg | Neg | 163 | 47 | No | No | No | No | No | No | No | Hysterectomy | 14-Dec-2020 | Ukraine | INO | Prospective | Active | |||||||||
63 | 02-31632 | 025-31632-PL6 | Plasma | K2EDTA | 1.5 | Female | 38 | Caucasian | Slavic | Uterus | Uterine cancer | Squamous intraepithelial lesion | Non-cancer | 2,5*0,8*0,8 | Neg | Neg | Neg | 163 | 47 | No | No | No | No | No | No | No | Hysterectomy | 14-Dec-2020 | Ukraine | INO | Prospective | Active | |||||||||
64 | 02-31632 | 025-31632-PL7 | Plasma | K2EDTA | 1.8 | Female | 38 | Caucasian | Slavic | Uterus | Uterine cancer | Squamous intraepithelial lesion | Non-cancer | 2,5*0,8*0,8 | Neg | Neg | Neg | 163 | 47 | No | No | No | No | No | No | No | Hysterectomy | 14-Dec-2020 | Ukraine | INO | Prospective | Active | |||||||||
65 | 02-31632 | 025-31632-PL8 | Plasma | K2EDTA | 2 | Female | 38 | Caucasian | Slavic | Uterus | Uterine cancer | Squamous intraepithelial lesion | Non-cancer | 2,5*0,8*0,8 | Neg | Neg | Neg | 163 | 47 | No | No | No | No | No | No | No | Hysterectomy | 14-Dec-2020 | Ukraine | INO | Prospective | Active | |||||||||
66 | 02-31632 | 025-31632-PL9 | Plasma | K2EDTA | 2 | Female | 38 | Caucasian | Slavic | Uterus | Uterine cancer | Squamous intraepithelial lesion | Non-cancer | 2,5*0,8*0,8 | Neg | Neg | Neg | 163 | 47 | No | No | No | No | No | No | No | Hysterectomy | 14-Dec-2020 | Ukraine | INO | Prospective | Active | |||||||||
67 | 02-31632 | 025-31632-PL10 | Plasma | K2EDTA | 2 | Female | 38 | Caucasian | Slavic | Uterus | Uterine cancer | Squamous intraepithelial lesion | Non-cancer | 2,5*0,8*0,8 | Neg | Neg | Neg | 163 | 47 | No | No | No | No | No | No | No | Hysterectomy | 14-Dec-2020 | Ukraine | INO | Prospective | Active | |||||||||
68 | 24872 | 24872-PL6 | Plasma | K2EDTA | 2 | Female | 58 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1a | Nx | Mx | G1 | IA | 1,5*1*0,2 | Neg | Neg | Neg | 170 | 87 | No | No | No | No | No | No | No | Panhysterectomy type I | 16-Jul-2020 | Ukraine | POLOD | Prospective | Active | ||||
69 | 24872 | 24872-PL7 | Plasma | K2EDTA | 2 | Female | 58 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1a | Nx | Mx | G1 | IA | 1,5*1*0,2 | Neg | Neg | Neg | 170 | 87 | No | No | No | No | No | No | No | Panhysterectomy type I | 16-Jul-2020 | Ukraine | POLOD | Prospective | Active | ||||
70 | 24872 | 24872-PL8 | Plasma | K2EDTA | 2 | Female | 58 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1a | Nx | Mx | G1 | IA | 1,5*1*0,2 | Neg | Neg | Neg | 170 | 87 | No | No | No | No | No | No | No | Panhysterectomy type I | 16-Jul-2020 | Ukraine | POLOD | Prospective | Active | ||||
71 | 24872 | 24872-PL9 | Plasma | K2EDTA | 2 | Female | 58 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1a | Nx | Mx | G1 | IA | 1,5*1*0,2 | Neg | Neg | Neg | 170 | 87 | No | No | No | No | No | No | No | Panhysterectomy type I | 16-Jul-2020 | Ukraine | POLOD | Prospective | Active | ||||
72 | 24872 | 24872-PL10 | Plasma | K2EDTA | 2 | Female | 58 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1a | Nx | Mx | G1 | IA | 1,5*1*0,2 | Neg | Neg | Neg | 170 | 87 | No | No | No | No | No | No | No | Panhysterectomy type I | 16-Jul-2020 | Ukraine | POLOD | Prospective | Active | ||||
73 | 23593 | 23593-PL6 | Plasma | K2EDTA | 2 | Female | 62 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT2 | pNx | M0 | G2 | II | 6*5*1,5 | Neg | Neg | Neg | Panhysterectomy | 6-Nov-2020 | Ukraine | POLOD | Prospective | Active | |||||||||||||
74 | 23593 | 23593-PL7 | Plasma | K2EDTA | 2 | Female | 62 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT2 | pNx | M0 | G2 | II | 6*5*1,5 | Neg | Neg | Neg | Panhysterectomy | 6-Nov-2020 | Ukraine | POLOD | Prospective | Active | |||||||||||||
75 | 23593 | 23593-PL8 | Plasma | K2EDTA | 2 | Female | 62 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT2 | pNx | M0 | G2 | II | 6*5*1,5 | Neg | Neg | Neg | Panhysterectomy | 6-Nov-2020 | Ukraine | POLOD | Prospective | Active | |||||||||||||
76 | 23593 | 23593-PL9 | Plasma | K2EDTA | 2 | Female | 62 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT2 | pNx | M0 | G2 | II | 6*5*1,5 | Neg | Neg | Neg | Panhysterectomy | 6-Nov-2020 | Ukraine | POLOD | Prospective | Active | |||||||||||||
77 | 23593 | 23593-PL10 | Plasma | K2EDTA | 2 | Female | 62 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT2 | pNx | M0 | G2 | II | 6*5*1,5 | Neg | Neg | Neg | Panhysterectomy | 6-Nov-2020 | Ukraine | POLOD | Prospective | Active | |||||||||||||
78 | 20910 | 20910-SST1 | Serum | SST | 2 | Female | 67 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | T1c | Nx | G1 | I | 8,5х6cm | Neg | Neg | Neg | 158 | 62 | No | No | No | No | No | No | No | Panhysterectomy | 21-Mar-2019 | Ukraine | POLOD | Prospective | Active | |||||
79 | 20910 | 20910-SST2 | Serum | SST | 2 | Female | 67 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | T1c | Nx | G1 | I | 8,5х6cm | Neg | Neg | Neg | 158 | 62 | No | No | No | No | No | No | No | Panhysterectomy | 21-Mar-2019 | Ukraine | POLOD | Prospective | Active | |||||
80 | 20910 | 20910-SST3 | Serum | SST | 2 | Female | 67 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | T1c | Nx | G1 | I | 8,5х6cm | Neg | Neg | Neg | 158 | 62 | No | No | No | No | No | No | No | Panhysterectomy | 21-Mar-2019 | Ukraine | POLOD | Prospective | Active | |||||
81 | 20910 | 20910-SST4 | Serum | SST | 2 | Female | 67 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | T1c | Nx | G1 | I | 8,5х6cm | Neg | Neg | Neg | 158 | 62 | No | No | No | No | No | No | No | Panhysterectomy | 21-Mar-2019 | Ukraine | POLOD | Prospective | Active | |||||
82 | 20910 | 20910-SST5 | Serum | SST | 2 | Female | 67 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | T1c | Nx | G1 | I | 8,5х6cm | Neg | Neg | Neg | 158 | 62 | No | No | No | No | No | No | No | Panhysterectomy | 21-Mar-2019 | Ukraine | POLOD | Prospective | Active | |||||
83 | 02-25704 | 02-25704-PL1 | Plasma | K2EDTA | 1.5 | Female | 61 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1b | Nx | Mx | G1 | IB | Neg | Neg | Neg | 166 | 81 | No | No | No | No | No | No | No | Hysterectomy | 4-Mar-2021 | Ukraine | ZSN | Prospective | Active | |||||
84 | 02-25704 | 02-25704-PL2 | Plasma | K2EDTA | 1.3 | Female | 61 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1b | Nx | Mx | G1 | IB | Neg | Neg | Neg | 166 | 81 | No | No | No | No | No | No | No | Hysterectomy | 4-Mar-2021 | Ukraine | ZSN | Prospective | Active | |||||
85 | 02-25704 | 02-25704-PL3 | Plasma | K2EDTA | 1.3 | Female | 61 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1b | Nx | Mx | G1 | IB | Neg | Neg | Neg | 166 | 81 | No | No | No | No | No | No | No | Hysterectomy | 4-Mar-2021 | Ukraine | ZSN | Prospective | Active | |||||
86 | 02-25704 | 02-25704-PL4 | Plasma | K2EDTA | 1.4 | Female | 61 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1b | Nx | Mx | G1 | IB | Neg | Neg | Neg | 166 | 81 | No | No | No | No | No | No | No | Hysterectomy | 4-Mar-2021 | Ukraine | ZSN | Prospective | Active | |||||
87 | 02-25704 | 02-25704-PL5 | Plasma | K2EDTA | 1.3 | Female | 61 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1b | Nx | Mx | G1 | IB | Neg | Neg | Neg | 166 | 81 | No | No | No | No | No | No | No | Hysterectomy | 4-Mar-2021 | Ukraine | ZSN | Prospective | Active | |||||
88 | 02-25704 | 02-25704-PL6 | Plasma | K2EDTA | 1.3 | Female | 61 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1b | Nx | Mx | G1 | IB | Neg | Neg | Neg | 166 | 81 | No | No | No | No | No | No | No | Hysterectomy | 4-Mar-2021 | Ukraine | ZSN | Prospective | Active | |||||
89 | 02-25704 | 02-25704-PL7 | Plasma | K2EDTA | 1.4 | Female | 61 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1b | Nx | Mx | G1 | IB | Neg | Neg | Neg | 166 | 81 | No | No | No | No | No | No | No | Hysterectomy | 4-Mar-2021 | Ukraine | ZSN | Prospective | Active | |||||
90 | 02-25704 | 02-25704-PL8 | Plasma | K2EDTA | 1.2 | Female | 61 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1b | Nx | Mx | G1 | IB | Neg | Neg | Neg | 166 | 81 | No | No | No | No | No | No | No | Hysterectomy | 4-Mar-2021 | Ukraine | ZSN | Prospective | Active | |||||
91 | 02-25704 | 02-25704-PL9 | Plasma | K2EDTA | 1.3 | Female | 61 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1b | Nx | Mx | G1 | IB | Neg | Neg | Neg | 166 | 81 | No | No | No | No | No | No | No | Hysterectomy | 4-Mar-2021 | Ukraine | ZSN | Prospective | Active | |||||
92 | 02-25704 | 02-25704-PL10 | Plasma | K2EDTA | 1.2 | Female | 61 | Caucasian | Slavic | Uterus | Uterine cancer | Endometrial carcinoma | Cancer | pT1b | Nx | Mx | G1 | IB | Neg | Neg | Neg | 166 | 81 | No | No | No | No | No | No | No | Hysterectomy | 4-Mar-2021 | Ukraine | ZSN | Prospective | Active | |||||
93 | 02-35211 | 02-35211-PL1 | Plasma | K2EDTA | 1.5 | Female | 69 | Caucasian | Slavic | Uterus | Uterine cancer | Carcinosarcoma | Cancer | T2 | N0 | M0 | G3 | II | Neg | Neg | Neg | 158 | 79 | No | No | No | No | No | No | No | Hysterectomy | 19-Feb-2021 | Ukraine | VIN | Prospective | Active | |||||
94 | 02-35211 | 02-35211-PL2 | Plasma | K2EDTA | 1.5 | Female | 69 | Caucasian | Slavic | Uterus | Uterine cancer | Carcinosarcoma | Cancer | T2 | N0 | M0 | G3 | II | Neg | Neg | Neg | 158 | 79 | No | No | No | No | No | No | No | Hysterectomy | 19-Feb-2021 | Ukraine | VIN | Prospective | Active | |||||
95 | 02-35211 | 02-35211-PL3 | Plasma | K2EDTA | 1.5 | Female | 69 | Caucasian | Slavic | Uterus | Uterine cancer | Carcinosarcoma | Cancer | T2 | N0 | M0 | G3 | II | Neg | Neg | Neg | 158 | 79 | No | No | No | No | No | No | No | Hysterectomy | 19-Feb-2021 | Ukraine | VIN | Prospective | Active | |||||
96 | 02-35211 | 02-35211-PL4 | Plasma | K2EDTA | 1.5 | Female | 69 | Caucasian | Slavic | Uterus | Uterine cancer | Carcinosarcoma | Cancer | T2 | N0 | M0 | G3 | II | Neg | Neg | Neg | 158 | 79 | No | No | No | No | No | No | No | Hysterectomy | 19-Feb-2021 | Ukraine | VIN | Prospective | Active | |||||
97 | 02-35211 | 02-35211-PL5 | Plasma | K2EDTA | 1.5 | Female | 69 | Caucasian | Slavic | Uterus | Uterine cancer | Carcinosarcoma | Cancer | T2 | N0 | M0 | G3 | II | Neg | Neg | Neg | 158 | 79 | No | No | No | No | No | No | No | Hysterectomy | 19-Feb-2021 | Ukraine | VIN | Prospective | Active | |||||
98 | 02-35211 | 02-35211-PL6 | Plasma | K2EDTA | 1.5 | Female | 69 | Caucasian | Slavic | Uterus | Uterine cancer | Carcinosarcoma | Cancer | T2 | N0 | M0 | G3 | II | Neg | Neg | Neg | 158 | 79 | No | No | No | No | No | No | No | Hysterectomy | 19-Feb-2021 | Ukraine | VIN | Prospective | Active | |||||
99 | 02-35211 | 02-35211-PL7 | Plasma | K2EDTA | 1.5 | Female | 69 | Caucasian | Slavic | Uterus | Uterine cancer | Carcinosarcoma | Cancer | T2 | N0 | M0 | G3 | II | Neg | Neg | Neg | 158 | 79 | No | No | No | No | No | No | No | Hysterectomy | 19-Feb-2021 | Ukraine | VIN | Prospective | Active | |||||
100 | 02-35211 | 02-35211-PL8 | Plasma | K2EDTA | 1.5 | Female | 69 | Caucasian | Slavic | Uterus | Uterine cancer | Carcinosarcoma | Cancer | T2 | N0 | M0 | G3 | II | Neg | Neg | Neg | 158 | 79 | No | No | No | No | No | No | No | Hysterectomy | 19-Feb-2021 | Ukraine | VIN | Prospective | Active |